[PHARMA] YoY Annualized Quarter Result on 30-Sep-2011 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
01-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- -8.82%
YoY- 23.21%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 1,994,440 1,838,372 1,773,256 1,537,593 1,336,309 1,302,520 1,303,204 7.34%
PBT 116,968 79,986 132,088 75,757 64,217 71,930 88,137 4.82%
Tax -40,162 -32,661 -37,856 -21,620 -21,201 -19,116 -30,154 4.89%
NP 76,805 47,325 94,232 54,137 43,016 52,814 57,982 4.79%
-
NP to SH 76,196 45,849 92,860 53,620 43,520 51,038 56,322 5.16%
-
Tax Rate 34.34% 40.83% 28.66% 28.54% 33.01% 26.58% 34.21% -
Total Cost 1,917,634 1,791,046 1,679,024 1,483,456 1,293,293 1,249,705 1,245,221 7.45%
-
Net Worth 507,513 473,857 496,623 464,307 424,715 407,610 374,390 5.19%
Dividend
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Div 55,239 33,903 39,227 - 67,041 38,514 25,672 13.61%
Div Payout % 72.50% 73.95% 42.24% - 154.05% 75.46% 45.58% -
Equity
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Net Worth 507,513 473,857 496,623 464,307 424,715 407,610 374,390 5.19%
NOSH 258,935 258,938 117,683 106,983 106,981 106,984 106,968 15.86%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 3.85% 2.57% 5.31% 3.52% 3.22% 4.05% 4.45% -
ROE 15.01% 9.68% 18.70% 11.55% 10.25% 12.52% 15.04% -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 770.25 709.97 1,506.80 1,437.23 1,249.11 1,217.49 1,218.30 -7.35%
EPS 29.43 17.71 78.91 50.12 40.68 47.71 52.65 -9.23%
DPS 21.33 13.09 33.33 0.00 62.67 36.00 24.00 -1.94%
NAPS 1.96 1.83 4.22 4.34 3.97 3.81 3.50 -9.20%
Adjusted Per Share Value based on latest NOSH - 106,933
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 138.38 127.55 123.04 106.68 92.72 90.37 90.42 7.34%
EPS 5.29 3.18 6.44 3.72 3.02 3.54 3.91 5.16%
DPS 3.83 2.35 2.72 0.00 4.65 2.67 1.78 13.61%
NAPS 0.3521 0.3288 0.3446 0.3222 0.2947 0.2828 0.2598 5.19%
Price Multiplier on Financial Quarter End Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 -
Price 4.63 4.82 7.55 5.90 4.98 4.09 3.24 -
P/RPS 0.60 0.68 0.50 0.41 0.40 0.34 0.27 14.22%
P/EPS 15.73 27.22 9.57 11.77 12.24 8.57 6.15 16.93%
EY 6.36 3.67 10.45 8.49 8.17 11.66 16.25 -14.46%
DY 4.61 2.72 4.42 0.00 12.58 8.80 7.41 -7.60%
P/NAPS 2.36 2.63 1.79 1.36 1.25 1.07 0.93 16.78%
Price Multiplier on Announcement Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 -
Price 4.45 4.72 8.25 5.90 4.92 3.93 3.35 -
P/RPS 0.58 0.66 0.55 0.41 0.39 0.32 0.27 13.58%
P/EPS 15.12 26.66 10.46 11.77 12.09 8.24 6.36 15.51%
EY 6.61 3.75 9.56 8.49 8.27 12.14 15.72 -13.43%
DY 4.79 2.77 4.04 0.00 12.74 9.16 7.16 -6.47%
P/NAPS 2.27 2.58 1.95 1.36 1.24 1.03 0.96 15.41%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment